Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
NCT00003470
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Anaplastic Astrocytoma
Interventions
DRUG:
Antineoplaston therapy (Atengenal + Astugenal)
Sponsor
Burzynski Research Institute